Navigation Links
CardioDynamics Agrees to be Acquired by SonoSite for $1.35 Per Share
Date:6/9/2009

ician office sales channel and large installed physician base. Through this merger we are joining an industry leader in point of care medicine who shares our vision of creating non-invasive technologies that improve outcomes and reduce the cost of patient care. The acquisition will accelerate the expansion of both SonoSite's and CardioDynamics' cardiovascular platforms and benefit the customers, employees and shareholders of both companies."

Kevin M. Goodwin, SonoSite President and CEO, stated, "The acquisition of CardioDynamics is part of a strategic initiative that moves SonoSite forward toward our long-stated goal of adding clinical value and reducing healthcare system costs in cardiovascular disease management. CardioDynamics is the platform we will build upon to achieve this goal. Additionally, CardioDynamics has established a solid direct sales channel in the U.S. with 38 sales representatives calling on cardiologists, internal medicine and family medicine practitioners, primarily in physician office settings. We believe we can leverage this channel to build on our existing footprint in point of care markets."

Rhonda F. Rhyne, CardioDynamics President, added, "We sincerely thank our employees, customers and partners for their contributions in making ICG an important part of cardiovascular care for the over 12,000 physicians who use ICG daily. We are excited for the opportunity to combine with SonoSite and leverage our innovative product portfolios and sales channels through each other's existing customer base. This will enable both companies to extend our reach to even more physicians and hospitals for the benefit of patients. Additionally, we expect that the acquisition of CardioDynamics by SonoSite will provide the incremental resources necessary to help make ICG a cardiovascular standard of care."

Cain Brothers & Company LLC acted as financial advisor and Pillsbury Winthrop Shaw Pittman LLP acted
'/>"/>

SOURCE CardioDynamics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase
2. CardioDynamics BioZ(R) ICG Technology Integrates with General Electric Healthcares Centricity(R) Electronic Medical Record (EMR) System
3. CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Companys Common Stock and Trading in Post-split Shares Begins May 9, 2008
4. CardioDynamics Receives Nasdaq Letter of Non-Compliance With Minimum Bid Price Requirement
5. CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series
6. CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego
7. CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility
8. CardioDynamics Provides 2007 Shareholder Meeting Update
9. MannKind Agrees with Pfizer on the Purchase of Frankfurt Insulin Manufacturing Plant
10. PharmaNet Development Group Agrees to be Acquired by JLL Partners
11. AEterna Zentaris Agrees to Sell Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 2015 - Development of a ... the VOLVOX Platform - To be Presented on Tuesday, ...  Supramolecular Assembly of Antibody-drug Conjugates Using an anti-HER2 Monoclonal ... Sunday, Apr 19, 1:00 PM EST Invictus ... today announced that the company,s novel computational platform technology ...
(Date:4/20/2015)... Whitehouse Laboratories is pleased and overly ... recent Food and Drug Administration (FDA) inspection and received ... day, GMP compliance inspection, as based upon 21CFR Parts ... April 6th and was granted NAI (no action indicated) ... strict Good Manufacturing Practice (GMP) quality system required by ...
(Date:4/17/2015)... , April 17, 2015 /PRNewswire/ - SQI Diagnostics ... and diagnostics company that develops and commercializes proprietary ... today announced that it has received approval from ... of 5,126,044 outstanding common share purchase warrants ("the ... connection with the Company,s May 2013 private placement ...
(Date:4/17/2015)... 17, 2015 BellBrook Labs announced ... support for the powerful Orthogonal Pooled Screening (OPS) ... Center at the Lankenau Institute for Medical Research ... to measurably improve successful drug discovery outcomes using ... rare, drug-like libraries available nowhere else, coupled to ...
Breaking Biology Technology:Invictus Oncology Announces Two Posters to be Presented Describing its Platform Technology on Supramolecular Therapeutics at the American Association for Cancer Research Annual Meeting, 2015 2Whitehouse Laboratories Completes FDA Inspection with No Form 483 – No Observations 2Whitehouse Laboratories Completes FDA Inspection with No Form 483 – No Observations 3SQI Diagnostics to Extend Warrant Expiry 2SQI Diagnostics to Extend Warrant Expiry 3BellBrook Labs and Lankenau Institute Partner to Accelerate Drug Discovery using Orthogonal Pooled Screening 2
... Insmed Inc. (Nasdaq CM: INSM ... host a conference call on Wednesday, May 13th at ... the first quarter 2009. Insmed intends to issue ... opens on May 13th.To participate in the live conference ...
... - Fourth Quarter 2008 Revenue Increased 28.6% to $14.1 Million, with Net, ... - 2008 Revenues Increased 23.5% to $59.1 Million vs. 2007, ... 20.1%, - 2008 Net Income Increased 13.7% to $4.1 Million ... - 2008 Cash Flow from Operations was $5.9 million, , ...
... Akaza Research will be conducting a presentation and exhibiting OpenClinica at ... Colorado Convention Center in Denver, CO. , ... Denver, ... Exhibition of the Association of Clinical Research Professionals (ACRP) will include ...
Cached Biology Technology:Insmed to Host First Quarter 2009 Conference Call 2China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 2China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 3China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 4China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 5China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 6China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 7China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 8China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 9China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 10China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 11Akaza Research to Present OpenClinica at ACRP Global Conference & Exhibition 2
(Date:4/20/2015)... -- Huntington Memorial Hospital is the first facility in ... wireless monitoring sensor to manage heart failure (HF). The ... heart failure monitoring device that has been proven to ... manage heart failure. The CardioMEMS HF System ... artery (PA) during a non-surgical procedure to directly measure ...
(Date:4/20/2015)... 2015 The announcement comes as ... Records Management (GRM), Ireland,s foremost records ... Having built up an impressive track record of clients within ... within the records management sector in Dubai ... GCC staffbase and employ a further eight staff members at ...
(Date:4/17/2015)... 17, 2015 Increasing ... technological advancement to drive biometric systems market in ...   According to a recently released ... &  Opportunities, 2020 ", biometric systems market in ... growth at CAGR of over 22% through 2020. ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... have published a step by step plan to one-day end ... developing plants that produce their own fertilizer. , ... required to produce nitrogen fertilizers has pushed the world-wide cost ... says that while they are necessary for high yields, those ...
... LOVE YOU! A red splash on a toxic butterfly,s wing ... mimic the wing pattern of another toxic species in the area. ... DON,T EAT US! , Now several research teams that ... butterflies mimic each other,s red wing patterns through changes in the ...
... Irvine, Calif., July 21, 2011 For 150 years ... the best-known examples of this is how poisonous butterflies from ... in effect joining forces to warn predators, "Don,t eat us," ... international team of researchers led by Robert Reed, UC Irvine ...
Cached Biology News:An eye gene colors butterfly wings red 2UCI-led butterfly study sheds light on convergent evolution 2
... combines world-class performance hardware, Cerity Networked Data ... support and columns, as well as our ... lets you reach uncompromising results and make ... The Agilent 6820 GC system is not ...
... short years since publication of the best-selling ... acclaimed Protein Protocols Handbook, there have been ... In recognition of the level of attention ... of new methodologies directed to study them, ...
... often call for critical, but time-consuming ... refines siRNA transfection protocols resulting in ... can be used to efficiently transfect ... without increased cytotoxicity. From start ...
... is a new-generation siRNA transfection reagent that ... 1 nM siRNA in a wide variety ... cell viability. Using low siRNA concentrations avoids ... when transfecting siRNA at higher concentrations, thereby ...
Biology Products: